Skip to content

Basket

You currently have no items in your basket.

PD-1

cancer; immune checkpoints; programmed cell death protein 1 (PD-1); programmed death ligand 1 (PD-L1)

Our Immune Checkpoint Partners

View all
  • Bio X Cell
  • ACRO Biosystems
  • Arigo Bio

Programmed cell death protein 1 (PD-1), alternatively referred to as CD279, is an immunoglobulin superfamily member. It is expressed by activated T-cells and plays an important role in subsiding immune responses and promoting tolerance to self-antigens by suppressing T-cell activity. PD-1 has two natural ligands, known as PD-L1 (also known as CD274) and PD-L2 (CD273), that are mainly expressed by antigen presenting cells. Since over-expression of PD-L1 is common in many tumours, several monoclonal antibody therapeutics have been developed to block the PD-1/PD-L1 interaction. These include nivolumab (OPDIVO®) and pembrolizumab (Keytruda®), which have seen clinical success in treating melanoma.

PD-1 related antibodies from preferred suppliers:

Below are more purified versions

for more information on the differences between InVivoMAb and InVivoPlus please click HERE!

PD-1 related proteins from preferred suppliers:

PD-1 related Conjugated proteins:

PD-1 related ELISA kits from preferred suppliers:

We use cookies to give you the best experience of using this website. By continuing to use this site, you accept our use of cookies. Please read our Cookie Policy for more information.